People suffering from psoriasis reported quick and extensive improvement of the psoriasis skin condition with new drug. The study published in The Lancet journal. 40% of people reported a complete clearance of psoriatic plaques after 12 weeks of treatment with the new drug and over 90% showed improvement.
Researchers have successfully engineered E coli bacteria to produce new forms of antibiotics — including three that show promise in fighting drug-resistant bacteria. Blaine A Pfeifer, an associate professor of chemical and biological engineering in the University at Buffalo School of Engineering and Applied Sciences, has been studying how to engineer Escherichia coli (E coli) to generate new varieties of erythromycin, a popular antibiotic.

